Skip to content

GoodRx Holdings, Inc. GDRX Balance Sheet Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$235.71M-21.7%$261.82M-41.6%$273.53M-35.5%$281.32M-46.4%$300.98M-43.6%
$232.72M+45.3%$235.75M+61.5%$203.74M+55.8%$189.03M+16.8%$160.12M+10.6%
$1.27B+134%$643.1M-2.5%$565.52M-9.8%$550.61M-26.6%$540.21M-26.3%
$11.74M+2.0%$12.27M-3.1%$11.28M-17.2%$10.73M-26.0%$11.51M-25.0%
$430.33M+2.0%$430.33M+4.8%$421.72M+2.7%$421.72M+2.7%$421.72M+2.7%
$61.17M-10.5%$64.08M+23.0%$62.77M+16.1%$65.57M+17.0%$68.36M+17.6%
$2.02B+56.0%$1.4B+1.2%$1.33B-2.2%$1.32B-10.6%$1.3B-10.9%
$88.07M+50.1%$88.8M+15.4%$83.53M-15.7%$67.2M-43.8%$58.67M-46.4%
$8.63M+36.8%$6.71M+11.1%$6.28M-0.7%$6.08M+1.5%$6.31M-3.4%
$5M0.0%$5M0.0%$5M+33.3%$5M-28.9%$5M-28.9%
$859.2M+731%$246M+98.5%$181.86M+59.0%$130.91M+27.7%$103.38M-11.3%
$482.42M-0.7%$483.26M-0.7%$484.11M-0.7%$484.97M-24.9%$485.84M-24.9%
$1.4B+118%$787.8M+18.7%$724.8M+10.1%$675.68M-16.2%$640.92M-22.1%
$34K-5.6%$34K-10.5%$34K-10.5%$35K-7.9%$36K-5.3%
-$1.41B+1.4%-$1.41B+2.1%-$1.42B+2.2%-$1.42B+2.4%-$1.43B+2.0%
$621.99M-4.9%$616.26M-15.0%$600.71M-13.7%$643.03M-3.9%$654.35M+3.7%
$2.02B+56.0%$1.4B+1.2%$1.33B-2.2%$1.32B-10.6%$1.3B-10.9%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are GoodRx Holdings, Inc.'s total assets?
GoodRx Holdings, Inc. (GDRX) holds $2.0B in total assets, up 56.0% year over year.
How much debt does GoodRx Holdings, Inc. have?
GoodRx Holdings, Inc. carries $541.4M in total debt against $622.0M of shareholders' equity, a debt-to-equity ratio of 0.87.
How much cash does GoodRx Holdings, Inc. have?
GoodRx Holdings, Inc. holds $235.7M in cash and equivalents.
Can GoodRx Holdings, Inc. cover its short-term obligations?
Its current ratio is 1.47 — current assets exceed current liabilities.
Where does GoodRx Holdings, Inc.'s balance sheet data come from?
Every line is extracted from GoodRx Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.